Researchers have important roles to play in ensuring that biotechnology companies obtain broader patent protection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
In re Deuel, 34 U.S.P.Q.2d (BNA) 1210 (Fed. Cir. 1995).
US Const, art. I § 8. (“To promote the progress of science and useful arts, by securing for limited times to authors and inventors the exclusive right to their respective writings and discoveries.”)
35 U.S.C.§112(1996).
In re Wright, 27 U.S.P.Q.2d (BNA) 1510 (Fed. Cir. 1993).
In re Wright, 27 U.S.P.Q.2d (BNA) at 1515.
190U.S.P.Q.214(1976).
The organometallic complex formed had the formula MXn(HAPA)m, wherein HAPA is a hexaalkylphosphoramide, MX is a metal salt, m is an integer from 1 to 8, and n is an integer from 1 to 4.
56 U.S. (15 How.) 62 (1854).
18 U.S.P.Q.2d (BNA) 1016 (Fed. Cir. 1991).
Id at 1O28.
Id. at 1216.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chahine, K. Going beyond the native: Protecting DMA and protein patents. Nat Biotechnol 15, 183–185 (1997). https://doi.org/10.1038/nbt0297-183
Issue Date:
DOI: https://doi.org/10.1038/nbt0297-183
